Next Article in Journal
Antioxidant Activity in Bee Products: A Review
Next Article in Special Issue
Grape Stem Extracts with Potential Anticancer and Antioxidant Properties
Previous Article in Journal
Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Evaluation of Chemical Composition, Radical Scavenging and Antitumor Activities of Satureja hortensis L. Herb Extracts
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 10
Issue 1
10.3390/antiox10010070
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

UPLC-ESI-Q-TOF-MS-Based Metabolite Profiling, Antioxidant and Anti-Inflammatory Properties of Different Organ Extracts of Abeliophyllum distichum

by
Tong-Kewn Yoo
,
Won Tae Jeong
,
Jun Gu Kim
,
Hyo Seong Ji
,
Min-A Ahn
,
Jong-Wook Chung
,
Heung Bin Lim
* and
Tae Kyung Hyun
*
Department of Industrial Plant Science and Technology, College of Agricultural, Life and Environmental Sciences, Chungbuk National University, Cheongju 28644, Korea
*
Authors to whom correspondence should be addressed.
Antioxidants 2021, 10(1), 70; https://doi.org/10.3390/antiox10010070
Submission received: 11 December 2020 / Revised: 5 January 2021 / Accepted: 6 January 2021 / Published: 7 January 2021
(This article belongs to the Special Issue Anti-inflammatory and Antioxidant Properties of Plant Extracts)
Browse Figures
Versions Notes

Abstract

:
Plant extracts have gained more attention as natural therapeutic agents against inflammation characterized by an overproduction of several inflammatory mediators such as reactive oxygen species and pro-inflammatory cytokines. Although Abeliophyllum distichum Nakai is generally known for its ornamental value, recent pharmacological research has demonstrated its potential therapeutic properties. Thus, to further evaluate the applicability of A. distichum in the food, cosmetic, and medical industries, we identified the phytochemicals in three organ extracts (fruits: AF, branches: AB, leaves: AL) of A. distichum and determined their antioxidant and anti-inflammatory activities. Using UPLC-ESI-Q-TOF-MS, a total of 19 compounds, including dendromoniliside D, forsythoside B, isoacteoside, isomucronulatol 7-O-Glucoside, plantamajoside, and wighteone were identified in the A. distichum organ extracts. AB exhibited a strong reducing power, an oxygen radical antioxidant capacity, and radical scavenging values compared with other samples, whereas AL exhibited the best anti-inflammatory properties. Gene expression, western blot, and molecular docking analyses suggested that the anti-inflammatory effect of AL was mediated by its ability to suppress lipopolysaccharide (LPS)-induced production of reactive oxygen species and/or inhibit LPS-stimulated activation of extracellular signal-regulated protein kinases (ERK1/2) in RAW264.7 cells. Collectively, these results indicate that AL is a potential source of phytochemicals that could be used to treat inflammation-associated diseases.

1. Introduction

Inflammation is the response of the immune system against tissue injury caused by mechanical trauma, bacterial infections, chemical insult, burns, or other harmful agents [1]. Uncontrolled inflammation can lead to tissue and cell damage, chronic inflammation, neoplastic transformation, and is an important factor that influences the development of various chronic diseases [1]. Although the inhibitors of phospholipase A2 (PLA2) and cyclooxygenases (COX) such as steroidal anti-inflammatory drugs (SAIDs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to treat many inflammatory diseases [2,3], the therapeutic benefits of these drugs are limited by their adverse side effects, which are caused by drug resistance or non-selective inhibition [2,3,4].
In addition to their therapeutic benefits, many plants have been found to possess therapeutic compounds, and therefore, have become a major source of novel active compounds and precursors for the synthesis of novel drugs. In fact, approximately 50% of drugs derive directly or indirectly from plant species and their preparations [5]. For example, shikimic acid (3,4,5-trihydroxy-1-cyclohexene-1-carboxylic acid) has been used as a chemical precursor for the industrial synthesis of antiviral drugs Tamiflu (oseltamivir) [6,7]. Additionally, the anti-inflammatory drug Acheflan®, which is produced from Codia verbenacea essential oil, is another example of a plant-derived drug [8]. Importantly, several medicinal plants have been reported to contain natural anti-inflammatory compounds, and therefore could be used as alternative natural anti-inflammatory agents with minimal side effects [9].
Abeliophyllum distichum Nakai (common name white forsythia) is a deciduous flowering plant belonging to the Oleaceae family, which contains 24 genera and 688 species [10]. This plant belongs to a monotypic genus (i.e., a genus with only a single species), which highlights the importance of this plant as a unique genetic resource [11]. Although this plant has been cultivated as an ornamental plant in Korea, because of its horticultural value, recent studies have reported that A. distichum possesses several therapeutic properties, including antioxidant, anti-inflammatory, anti-melanogenic, anti-cancer, and anti-diabetic effects [11,12,13,14]. Recently, it has been shown that A. distichum leaf EtOH extract has a higher free radical scavenging activity than its stem extract, suggesting variation in biological activities in different organs of A. distichum [15]. Among phytochemicals in A. distichum, phenolic and phenylethanoid glycosides have been reported as multiple active compounds with therapeutic value [11,14]. For example, acteoside (phenylethanoid glycoside) and isoacteoside (dihydroxypheynylethyl glycoside) identified in leaves of A. distichum, exhibited antioxidant and anti-inflammatory activities, respectively [15,16], indicating that A. distichum could have functional applications in the cosmetic, biomedical, pharmaceutical, and other industries. While various studies have characterized the phenolic and phenylethanoid glycoside compounds from A. distichum, systematic investigation including the comparison of the metabolite composition in different organ and molecular mechanism underlying the anti-inflammatory effects is extremely limited.
Therefore, our study investigated and compared the antioxidant and anti-inflammatory activities of extracts obtained from leaves, branches, and fruits of A. distichum. In lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells, to investigate the role of A. distichum extracts in oxidative stress-induced inflammation, we analyzed the expression pattern of genes, NADPH oxidases (NOX1, NOX2), superoxide dismutase (SOD), catalase (CAT), NAD(P)H quinone oxidoreductase 1 (NQO1), and γ-glutamyl cysteine synthetase (GCLC), involved in reactive oxygen species (ROS) production or antioxidant systems. Additionally, to better understand the antioxidant and anti-inflammatory activities of A. distichum extracts, we performed metabolic analysis using ultra-performance liquid chromatography coupled with electrospray ionization-quadrupole-time of flight-mass spectrometry (UPLC-ESI-Q-TOF-MS).

2. Materials and Methods

2.1. Preparation and UPLC-ESI-Q-TOF-MS-Based Metabolomic Analysis of A. distichum Organ Extracts

Three different organs from A. distichum obtained from the Chungbuk National University research forest were lyophilized and ground into fine powder. The obtained powder (200 g) were extracted in methanol (MeOH, 1 L) for 24 h at room temperature. After filtration, the MeOH extracts of fruits (AF), branches (AB) and leaves (AL) were concentrated under vacuum in rotary evaporator at 40 °C, as described by Yoo et al. [14]. To investigate the antioxidant and anti-inflammatory activities, the 100 mg of each extract was dissolved in 1 mL dimethyl sulfoxide (DMSO).
For metabolic analysis, the samples were analyzed using ACQUITY UPLC system (Waters, Milford, MA, USA). Chromatographic separation was performed using a Waters ACQUITY UPLC column (BEH C18: 2.1 × 50 mm, 1.7 μm) at 35 °C with a 0.3 mL/min flow rate. A gradient elution was achieved using two mobile phases consisting of 0.1% (v/v) aqueous formic acid (mobile phase A) and acetonitrile (mobile phase B). Mass spectrometric analyses were performed using a Xevo G2 Q-TOF LC/MS mass spectrometer system (Waters, Milford, MA, USA) equipped with an ESI source in negative ion mode. The optimized parameters for the mass spectrometric analysis were the following: capillary voltage, 2.5 kV; cone voltage, 25 V; cone gas flow rate, 50 L/h; desolvation gas flow rate, 800 L/h; desolvation gas temp, 350 °C; source temperature 150 °C; collision energies, 30–35 eV. The mass range was set to 50–1200 m/z. All UPLC-ESI-Q-TOF-MS data were analyzed using the UNIFI software (ver. 1.8) and the ChemSpider database (http://www.chemspider.com/). Resolved peaks were further identified based on reported values from the literature.

2.2. Determination of Antioxidant Properties by Chemical-Based Assays

Reducing power was determined by monitoring Fe3+–Fe2+ transformation at 750 nm, and the oxygen radical antioxidant capacity (ORAC) value were determined by monitoring the inhibition of peroxyl radical-induced oxidation, as described by Choi et al. [17]. For reducing power assay, ascorbic acid (ASA) was used as a positive control. In addition, the area under the curve of the fluorescence decay curve was used to quantify the ORAC values, and the value was expressed as μM of Trolox equivalents (μM TE). To optimize the concentrations of extracts for antioxidant assays, we tested various concentration (0 to 400 μg/mL) of each extract, and presented data, which exhibited significantly different antioxidant activities between extracts.
The free radical scavenging activity of each extract was analyzed using 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,20-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS•+). To generate ABTS•+, 7 mM ABTS was mixed with 2.45 mM potassium persulfate, and incubated for 16 h in the dark. A total of 180 µL of DPPH solution (0.4 mM in 80% MeOH) or diluted ABTS•+ solution was plated in 96 well plates, and 20 µL of each extract (10 mg/mL) was added, followed by serial dilution to each well. The absorbance values were measured at 520 nm (for DPPH redical) or 734 nm (ABTS•+), and the RC50 (50% reduction of radicals) was determined using the graph plotted inhibition percentage against extract concentration. Butylated hydroxytoluene (BHT) was used as a positive control.
For hydroxyl radical scavenging assay, 100 μg/mL of each extract was mixed with 1 mL reaction buffer (2.8 mM 2-deoxy-2-ribose, 20 mM KH2PO4-KOH (pH 7.4), 100 μM FeCl3, 100 μM EDTA, 1.0 mM H2O2, and 100 μM ascorbic acid). After incubation for 1 h at 37 °C, 0.5 mL 2.8% TCA and 0.5 mL 1% aqueous TBA was added to the reaction mixtures. The absorbance was measured at 532 nm, after incubation for 30 min at 90 °C. Hydroxyl radical scavenging activity was calculated as described by Lee et al. [15].

2.3. Analysis of Nitric Oxide (NO) Production and Cell Viability

Lipopolysaccharide (LPS)-stimulated macrophage is a commonly used model to study the inflammation. To investigate the anti-inflammatory effect of A. distichum extracts, RAW264.7 murine macrophage cells (ATCC® TIB-71TM, ATCC, Rockville, MD, USA) were cultivated with each extract in the presence of 1 μg/mL LPS. After incubation for 24 h, the cultured medium was used to determine LPS-induced NO production using the Griess reagent and cell viability tests were conducted using MTT assay, as described by Choi et al. [11]. NO concentration was calculated based on a standard curve generated with sodium nitrite. For MTT assay, the resulting formazan crystals were dissolved in DMSO, and optical density was measured at 520 nm.

2.4. DCFH-DA (Dichlorofluorescein Diacetate) Assay

In the RAW264.7 cells, the level of intracellular ROS induced by LPS was detected using the DCFH-DA assay, as described by Choi et al. [11]. RAW264.7 cells were cultivated with or without AL in the presence of LPS. After incubation for 5 h, the cells were washed twice with Hank’s buffered salt solution (HBSS) and incubated with 20 μM of fresh DCFH-DA in HBSS for 30 min at 37 °C in a 5% CO2 incubator. DCF fluorescence was determined with fluorescence microplate reader (485 nm excitation and 525 nm emission).

2.5. Western Blot

Equal amounts of proteins extracted from RAW264.7 cells using the RIPA lysis buffer were separated with SDS-PAGE (10% gel) and transferred onto the PVDF membrane [14]. After blocking for 1 h with a 5% skim milk, the target proteins were detected using primary (iNOS, MEK1/2, p-MEK1/2, ERK1/2, p-ERK1/2, and β-actin) and HRP-conjugated secondary antibodies. The proteins were then visualized using a chemiluminescence system.

2.6. Quantitative Real-Time PCR (qRT-PCR)

The isolation of total RNA and cDNA synthesis were performed as described by Yoo et al. [14]. The expression patterns of each gene were analyzed using the Real-time PCR system (Bio-Rad, Hercules, CA, USA). The transcription levels of each gene (iNOS, COX-2, IL-6, NOX1, NOX2, SOD, CAT, NQO-1, and GCLC) were normalized to that of β-actin, which was used as an internal standard. The specific qRT-PCR primer pairs are listed in Table S1.

2.7. Statistical Analyses

The significant differences between mock control and treated samples were determined using one-way ANOVAs, Duncan multiple range, and Tukey’s honest significance tests. p values < 0.05 were regarded as statistically significant difference.

3. Results and Discussion

3.1. Identification of the Chemical Composition of A. distichum Organ Extracts Using UPLC-ESI-Q-TOF-MS

Although metabolomic approaches including liquid- and gas-chromatography-mass spectrometry have been used to identify and analyze the metabolites of several plants, UPLC-ESI-Q-TOF-MS is thought to be the most effective tool for the on-line structural elucidation of multiple components in plant extracts due to its mass measurement accuracy, high separation resolution, and excellent sensitivity [18]. To characterize the chemical composition of MeOH extracts obtained from A. distichum organs, untargeted qualitative analysis of the extracts was conducted via UPLC-ESI-Q-TOF-MS. The detected molecules were characterized by analyzing their fragmentation, which was obtained via ESI-MS in negative mode (Figure S1) coupled with literature data. As shown in Table 1, a total of 19 compounds including phenylpropanoids, phenolic acids, isoflavones, and terpenoids were identified. D-(−)-quinic acid (1), rutin (7), isoaceoside (12), and asiatic acid (19) were identified in all tested extracts. Isoacteoside (12) has been suggested as a major active compound of A. distichum leaf [16]. However, we found that isoaceoside (12) exist in leaves, as well as fruits and branches of A. distichum (Table 1). Moreover, five compounds including dendromoniliside D (2), plantamajoside (4), calceolarioside B (5), isomucronulatol 7-O-glucoside (10), and bulleyanin (17) were only identified in AL, whereas another four compounds were only found in AB. This organ-specific distribution of secondary metabolites was likely due to organ-specific metabolic shifts. In Korean black raspberry (Rubus coreanus Miquel), the flavonoid biosynthesis process shifts from proanthocyanidins to anthocyanins during the ripening process [19]. Similarly, organ-specific flavonoid metabolic shifts have been reported in various Scutellaria baicalensis organs [20]. Alternatively, metabolite production/modification may also be organ-specific. For instance, in Achyranthes bidentata, saponins are mainly synthesized in leaves, and transported and modified in roots [21]. The differential mRNA levels of genes involved in the biosynthesis of specific metabolites in different organs also supported the notion that metabolite production/modification is often organ-specific [17,22]. Therefore, differences in phytochemical compositions may affect the biological activities of different A. distichum organ extracts.

3.2. In-Vitro Antioxidant Properties of A. distichum Organ Extracts

Oxidative stress, which results from oxidant-antioxidant imbalance, deregulates a series of cellular functions, and causes various pathological conditions such as chronic inflammation, aging, asthma, carcinogenesis, cardiovascular dysfunction, diabetes, and neurodegenerative diseases [23]. Therefore, the development of alternative natural antioxidant agents with little or no side effects has attracted considerable attention. To characterize the antioxidant properties of MeOH extracts obtained from A. distichum organs, we tested the antioxidant activities of different samples using the reducing power assay and ORAC assay, which are based on single-electron transfer and hydrogen atom transfer reactions, respectively. As shown in Figure 1A, antioxidant activity varied among the different organ extracts used in this study. AB (OD750 value = 0.23) exhibited the highest reducing potential, followed by AF (OD750 value = 0.18). Similarly, based on the ORAC assay, AB extracts exerted the highest inhibitory effect on peroxyl radical-induced oxidation (Figure 1B). In addition, AB displayed a stronger ability to decrease DPPH free radicals (RC50 = 294.5 ± 16.4 µg/mL, Figure 1C), ABTS cation radicals (RC50 = 36.0 ± 0.63 µg/mL, Figure 1D), and hydroxyl radical scavenging activity (86 ± 0.97%) than other organ extracts, suggesting that A. distichum branches possess a stronger antioxidant activity than that of the other analyzed organs. Recently, it has been shown that antioxidant activity of A. distichum leaf EtOH extracts is slightly higher than A. distichum stem EtOH extracts [15]. The variation of antioxidant activity might be mediated by phytochemical compositions and concentrations, which are influenced by season, climatic conditions, stages of maturity, and extraction conditions.
Plant-derived polyphenolic compounds possess several beneficial biological properties, including antioxidant, antibacterial, anti-inflammatory, anti-cancer, and anti-diabetic activities [24]. In A. distichum organ extracts, AB contained the highest amount of phenolic compounds (59.8 ± 1.34 μg/mg GAE) but also exhibited the lowest total flavonoid content (14.5 ± 1.71 μg/mg QE) among the examined extracts (Figure S2). Additionally, various polyphenolic compounds including α-glucosyl hesperidin (3), and wighteone (16) were identified in AB (Table 1). Among them, wighteone (16), which has been isolated from Cudrania fruticosa root [25], whole-plant extracts of Lupinus texensis [26], Ficus tikoua root [27], and Erythrina stricta stem bark [28], exhibited antimicrobial and antioxidant activities [26,28]. Collectively, these findings indicate that differences in the antioxidant activities of organ extracts are likely mediated by differences in the compositions and concentrations of active compounds such as polyphenols.

3.3. Effects of A. distichum Organ Extracts on LPS-Induced NO Production

RAW264.7 cells, a monocyte/macrophage-like cell line, stimulated with LPS (i.e., a potent inducer of inflammation) are commonly used to screen for anti-inflammatory properties in plant extracts by measuring NO production. Therefore, to investigate whether A. distichum organ extracts possessed anti-inflammatory activity, the inhibitory effects of each organ extract on LPS-stimulated NO production in RAW264.7 cells were examined. As shown in Figure 2A, LPS significantly increased NO production by approximately 11-fold compared to LPS-untreated cells, while 50 μg/mL of AL suppressed LPS-induced NO production by more than 50% beyond the level of the DMSO-treated mock control. Additionally, AL treatment markedly decreased LPS-induced NO increases in a dose-dependent manner (Figure 2B). To assess whether AL affected cell viability, RAW264.7 cells were incubated with LPS in the presence of AL. Our results suggest that AL did not exhibit the cytotoxicity regardless of the presence of LPS (Figure 2C), suggesting that the inhibition of LPS-induced NO production by AL was not mediated by RAW264.7 cell viability.
In macrophage cells, NO is produced by NO synthase (NOS), which is further divided into three classes: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NO synthase (iNOS). eNOS and nNOS are known to be constitutively expressed, whereas iNOS is induced by inflammatory stimuli [29]. This suggests that LPS-induced NO production is mainly mediated by iNOS induction [30], indicating that the suppression of excessive iNOS-derived NO production can serve as a promising strategy to the treatment of inflammatory disorders. Thus, to investigate whether the inhibitory effect of AL on LPS-induced NO production was mediated by the suppression of iNOS, LPS-induced iNOS transcription and translation were determined in AL-treated RAW264.7 cells. LPS treatment significantly induced iNOS transcription within 24 h compared to non-treated cells. However, this expression level of LPS-induced iNOS was decreased by AL treatment (Figure 3A). Consistently with these findings, Western blot analyses elucidated an increase in iNOS protein expression in response to LPS, which was almost completely inhibited by AL (Figure 3B), suggesting that the inhibition of LPS-induced NO production by AL treatment was due to the inhibition of iNOS expression. iNOS-generated NO reportedly interacts with mitochondrial cytochrome c oxidase and competes with oxygen, resulting in a decrease in adenosine triphosphate production [31,32]. Therefore, the inhibitory effect of AL on iNOS-derived NO production in LPS-stimulated cells suggested that AL could be used as a plant-derived drug for the removal of cytotoxic NO.
In LPS-stimulated macrophages, inflammatory signaling is induced by the pro-inflammatory gene expression, resulting in the generation of pro-inflammatory mediators including NO, cyclooxygenase-2 (COX-2), iNOS, interleukin 6 (IL-6), and prostaglandin (PGE2) [33]. Therefore, many phytochemicals and plant extracts capable of reducing or inhibiting the production of pro-inflammatory mediators has been suggested as potential anti-inflammatory agents. To further analyze the anti-inflammatory properties of AL, we determined the expression levels of IL-6, and COX-2. As shown in Figure 4, LPS-induced expression of IL-6, and COX-2 was significantly decreased by AL in a dose-independent manner. Among the metabolic compounds identified in AL, plantamajoside (4) is known to exert anti-inflammatory effects via the inhibition of LPS-induced IL-6 production [34]. Additionally, calceolarioside B (5), phenylethanoid glycoside, has been exhibited to inhibit TNF-α-induced IL-6 production in MG-63 cells [35]. Furthermore, rutin (7) has been suggested as a candidate therapeutic agent for treatment of inflammatory diseases through inhibition of the high mobility group box 1-stimulated production of IL-6 [36], isoacteoside (12) significantly inhibited the production of phorbol 12-myristate 13-acetate and calcium ionophore A23187 (PMACI)-induced pro-inflammatory mediators in HMC-1 cells [16]. Therefore, the aforementioned compounds are likely responsible for the anti-inflammatory property of AL, suggesting that the anti-inflammatory activity of AL should be modulated by the suppression of pro-inflammatory mediators and cytokine production.

3.4. Effects of A. distichum Leaf Extract on LPS-Induced ROS Production in RAW264.7 Cells

In macrophages, LPS triggers the ROS production through the induction of NOXs and the inhibition of the antioxidant system [37,38], suggesting that the inhibition of ROS formation via the suppression of genes involved in ROS production, and/or enhancement of antioxidant mechanisms are all potential targets for the treatment of inflammatory disorders [39]. To analyze the effect of A. distichum organ extracts on LPS-induced ROS production in RAW264.7 cells, we determined the level of intracellular ROS using the fluorescent probe DCFH-DA. When RAW264.7 cells were treated with AL, the production of LPS-induced ROS was significantly suppressed in a dose-dependent manner (Figure 5A). Interestingly, AB did not inhibit LPS-induced ROS production, despite exhibiting strong antioxidant properties in our chemical-based assays (Figure 1). DCFH-DA is a common reagent used to detect intracellular ROS levels via the oxidation of DCFH to fluorescent DCF. LPS induced the production of hydroxyl radicals, hydrogen peroxide, and peroxinitrite, resulting in the induction of DCFH oxidation [40]. This reaction is inhibited when bioactive compounds stimulate the intracellular antioxidant defense system or act as ROS-scavengers once the cell membrane is compromised/breached [11,41]. Therefore, one possible explanation for the lack of inhibitory effects of AB on LPS-induced ROS levels might be the inability of the bioactive compounds in AB to penetrate weak cell membranes. To further characterize the inhibitory effect of AL on LPS-induced ROS production, we determined the transcription levels of genes involved in ROS generation and the antioxidant system. As shown in Figure 5B, the expression of LPS-induced NOX-1 and NOX-2, which are involved in LPS-induced oxidative stress [42], was inhibited by AL in a dose-independent manner, suggesting that AL suppressed LPS-induced ROS production via down-regulation of NOX-1 and NOX-2. However, AL did not significantly change the expression of SOD and CAT, important enzymes in cellular oxygen metabolism, in LPS-stimulated RAW264.7 cells (Figure 5C). In macrophages, the activation of nuclear factor erythroid 2-related factor 2 (Nrf2) plays an important role in cellular redox homeostasis via the induction of antioxidant and detoxifying enzymes [43]. In AL-treated RAW264.7 cells, we found the increasing expression levels of Nrf2-targeted antioxidant and detoxification enzymes, including NQO1 and GCLC (Figure 5D). Recently, it has been shown that plantamajoside (2) protects rat cardiomyocytes H9c2 cells against hypoxia/reoxygenation-induced injury via the enhancement of Nrf2-targeted antioxidant and detoxification pathways [44]. Although bioactive compounds in AL may also scavenge LPS-induced ROS, this finding suggests that the suppression of LPS-induced ROS by AL is likely mediated by either the inhibition of ROS production or the enhancement of the antioxidant system.

3.5. Effects of A. distichum Leaf Extract on the LPS-Induced MEK-ERK1/2 Pathway in RAW264.7 Cells

Mitogen-activated protein kinases (MAPKs), including ERK1/2, JNK, and p38, are well-characterized serine/threonine protein kinases that regulate fundamental biological processes and cellular responses such as proliferation, inflammation, apoptosis, and tumorigenesis [45]. In LPS-stimulated cells, MAPKs are activated either by the activation of signaling pathways or by LPS-induced ROS production [46,47]. The inhibition of MEK1/2 by the selective MEK inhibitor U0126 has been exhibited to inhibit the LPS-mediated induction of several inflammatory cytokines and PGE2 [48]. Additionally, the LPS-induced MEK/ERK1/2 pathway was inactivated by treatment with an extract obtained from the aerial (i.e., above-ground) structures of A. distichum [11]. Based on these findings, we hypothesized that AL regulates the LPS-MEK/ERK1/2 pathway in macrophages, although multiple pathways are activated in response to LPS. To test this hypothesis, we analyzed the inhibitory effect of AL on LPS-induced MEK/ERK1/2 activation. As shown in Figure 6, LPS treatment led to a dynamic activation of MEK1/2 and ERK1/2. Surprisingly, AL treatment was not enough to suppress the phosphorylation of MEK1/2, indicating that the anti-inflammatory effect of AL is not mediated by the inactivation of toll-like receptor 4 (TLR4)-dependent MEK signaling. However, LPS-induced activation of ERK1/2 was strongly inhibited by AL, and this inactivation was not mediated by the inhibition of de novo ERK1/2 protein synthesis and MEK1/2 activation. As described above, the inhibition of MEK1/2 activity suppressed LPS-induced inflammation [48]. Based on our analysis of the interaction between compounds in AL and MEK1/2 using a structure-based molecular docking approach, we found that dendromoniliside D (2) (−5.71 ± 0.15 kcal/mol) and isomucronulatol 7-O-glucoside (10) (−6.75 ± 0.38 kcal/mol) in AL had a higher binding affinity to MEK1 than U0126 (−5.32 ± 0.14 kcal/mol) (Table S2), indicating that the inactivation ERK1/2 was due to the inhibition of MEK activity via the bioactive compounds in AL. The MAPK phosphatases (MKPs) or dual-specificity phosphatases play as key negative regulators of MAPK cascades [49]. It has been shown that malvidin (i.e., a polyphenolic compound)-induced MKP-1 transcription is required for the suppression of LPS-induced TLR4 signaling [50]. Although further research is required to analyze the effect of AL on MPK induction, our findings indicated that inactivation of ERK1/2 by AL-induced MKPs led to the inhibition of LPS-induced inflammation, among other potential mechanisms.

4. Conclusions

To assess the bioactive compounds of A. distichum, UPLC-ESI-Q-TOF-MS approach was used to obtain a detailed profile of the metabolic compounds in three different organs of A. distichum. 19 compounds including dendromoniliside D (2), rutin (7), isomucronulatol 7-O-glucoside (10), forsythoside B (11), and isoacteoside (12) were identified in A. distichum organ extracts. Moreover, we determined the antioxidant and anti-inflammatory activities of A. distichum organ extracts. The gene expression analysis indicates that AL suppressed the LPS-induced ROS via the modification of antioxidant system. Furthermore, the molecular docking analysis indicates that isomucronulatol 7-O-glucoside (10) (−6.75 ± 0.38 kcal/mol) identified in AL exhibited good binding affinity to MEK1, suggesting that AL has an inhibitory effect on the LPS-induced pro-inflammatory mediator production through either the suppression of ROS production or the inhibition of ERK1/2 signaling. Collectively, these results indicate that AL contains phytochemicals that could be used to treat and control inflammatory diseases. Further in vivo studies are necessary to assess crucial physiological aspects of A. distichum extract administration, including its safety, bioavailability, and metabolism.

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-3921/10/1/70/s1, Figure S1: Chromatogram of A. distichum organ extracts obtained by UPLC-ESI-Q-TOF-MS in negative mode, Figure S2: Total phenolic content and flavonoid content in A. distichum organ extracts, Table S1: Primer sequences used in this study, Table S2: In silico defined molecular docking of some metabolic compounds to MEK1. Supplementary Methods: Determination of total phenolic content (TPC) and total flavonoid content (TFC), Molecular docking analysis.

Author Contributions

Conceptualization, T.-K.Y., H.B.L., J.-W.C., and T.K.H.; Investigation, T.-K.Y., W.T.J., J.G.K., H.S.J., and M.-A.A.; Methodology, H.B.L.; Writing—original draft preparation, T.-K.Y. and T.K.H.; Writing—review and editing, T.-K.Y., H.B.L., J.-W.C., and T.K.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the research grant from the National Research Foundation of Korea (NRF-2018R1D1A1B07043720) funded by the Ministry of Science, Korea.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to reasons of privacy.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018, 9, 7204–7218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Ramamoorthy, S.; Cidlowski, J.A. Corticosteroids. Mechanisms of action in health and disease. Rheum. Dis. Clin. N. Am. 2016, 42, 15–31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Süleyman, H.; Demircan, B.; Karagöz, Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol. Rep. 2007, 59, 247–258. [Google Scholar] [PubMed]
  4. Wongrakpanich, S.; Wongrakpanich, A.; Melhado, K.; Rangaswami, J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018, 9, 143–150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Veeresham, C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Technol. Res. 2012, 3, 200–201. [Google Scholar] [CrossRef] [PubMed]
  6. Singh, P.; Gupta, E.; Mishra, N.; Mishra, P. Shikimic acid as intermediary model for the production of drugs effective against influenza virus. Phytochem. Lead Compd. New Drug Discov. 2020, 245–256. [Google Scholar]
  7. Bochkov, D.V.; Sysolyatin, S.V.; Kalashnikov, A.I.; Surmacheva, I.A. Shikimic acid: Review of its analytical, isolation, and purification techniques from plant and microbial sources. J. Chem. Biol. 2012, 5, 5–17. [Google Scholar] [CrossRef] [Green Version]
  8. Perini, J.A.; Angeli-Gamba, T.; Alessandra-Perini, J.; Ferreira, L.C.; Nasciutti, L.E.; Machado, D.E. Topical application of Acheflan on rat skin injury accelerates wound healing: A histopathological, immunohistochemical and biochemical study. BMC Complement. Altern. Med. 2015, 30, 203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Azab, A.; Nassar, A.; Azab, A.N. Anti-inflammatory activity of natural products. Molecules 2016, 21, 1321. [Google Scholar] [CrossRef]
  10. Huang, Y.L.; Oppong, M.B.; Guo, Y.; Wang, L.Z.; Fang, S.M.; Deng, Y.R.; Gao, X.M. The Oleaceae family: A source of secoiridoids with multiple biological activities. Fitoterapia 2019, 136, 104155. [Google Scholar] [CrossRef]
  11. Choi, J.H.; Seo, E.J.; Sung, J.; Choi, K.M.; Kim, H.; Kim, J.S.; Lee, J.; Efferth, T.; Hyun, T.K. Polyphenolic compounds, antioxidant and anti-inflammatory effects of Abeliophyllum distichum Nakai extract. J. Appl. Bot. Food Qual. 2017, 90, 266–273. [Google Scholar]
  12. Jang, T.; Choi, J.; Kim, H.; Lee, E.; Han, M.; Lee, K.; Kim, D.; Park, J.-H. Whitening activity of Abeliophyllum distichum Nakai leaves according to the ratio of prethanol A in the extracts. Korean J. Plant Reources. 2018, 31, 667–674. [Google Scholar]
  13. Li, H.M.; Kim, J.K.; Jang, J.M.; Cui, C.B.; Lim, S.S. Analysis of the inhibitory activity of Abeliophyllum distichum leaf constituents against aldose reductase by using high-speed counter current chromatography. Arch. Pharm. Res. 2013, 36, 1104–1112. [Google Scholar] [CrossRef] [PubMed]
  14. Yoo, T.K.; Kim, J.S.; Hyun, T.K. Polyphenolic composition and anti-melanoma activity of white forsythia (Abeliophyllum distichum Nakai) organ extracts. Plants 2020, 9, 757. [Google Scholar] [CrossRef]
  15. Lee, H.D.; Kim, J.H.; Pang, Q.Q.; Jung, P.M.; Cho, E.J.; Lee, S. Antioxidant activity and acteoside analysis of Abeliophyllum distichum. Antioxidants 2020, 9, 1148. [Google Scholar] [CrossRef]
  16. Nam, S.Y.; Kim, H.Y.; Yoou, M.S.; Kim, A.H.; Park, B.J.; Jeong, H.J.; Kim, H.M. Anti-inflammatory effects of isoacteoside from Abeliophyllum distichum. Immunopharmacol. Immunotoxicol. 2015, 37, 258–264. [Google Scholar] [CrossRef]
  17. Choi, J.H.; Kim, H.; Hyun, T.K. Transcriptome analysis of Abeliophyllum distichum NAKAI reveals potential molecular markers and candidate genes involved in anthocyanin biosynthesis pathway. S. Afr. J. Bot. 2018, 116, 34–41. [Google Scholar] [CrossRef]
  18. Han, Y.X.; Wang, P.F.; Zhao, M.; Chen, L.M.; Wang, Z.M.; Liu, X.Q.; Gao, H.M.; Gong, M.X.; Li, H.; Zhu, J.Z.; et al. Chemical profiling of xueshuan xinmaining tablet by HPLC and UPLC-ESI-Q-TOF/MS. Evid. Based Complement. Altern. Med. 2018, 2018, 2781597. [Google Scholar] [CrossRef]
  19. Hyun, T.K.; Lee, S.; Rim, Y.; Kumar, R.; Han, X.; Lee, S.Y.; Lee, C.H.; Kim, J.Y. De-novo RNA sequencing and metabolite profiling to identify genes involved in anthocyanin biosynthesis in Korean black raspberry (Rubus coreanus Miquel). PLoS ONE 2014, 9, e88292. [Google Scholar] [CrossRef] [Green Version]
  20. Xu, J.; Yu, Y.; Shi, R.; Xie, G.; Zhu, Y.; Wu, G.; Qin, M. Organ-specific metabolic shifts of flavonoids in Scutellaria baicalensis at different growth and development stages. Molecules 2018, 23, 428. [Google Scholar] [CrossRef] [Green Version]
  21. Li, J.; Hu, Z. Accumulation and dynamic trends of triterpenoid saponin in vegetative organs of Achyranthus bidentata. J. Integr. Plant Biol. 2009, 51, 122–129. [Google Scholar] [CrossRef] [PubMed]
  22. Eom, S.H.; Lee, J.K.; Kim, H.; Hyun, T.K. De novo transcriptomic analysis to reveal functional genes involved in triterpenoid saponin biosynthesis in Oplopanax elatus NAKAI. J. Appl. Bot. Food Qual. 2017, 90, 25–31. [Google Scholar]
  23. Sindhi, V.; Gupta, V.; Sharma, K.; Bhatnagar, S.; Kumari, R.; Dhaka, N. Potential applications of antioxidants—A review. J. Pharm. Res. 2013, 7, 828–835. [Google Scholar] [CrossRef]
  24. Cory, H.; Passarelli, S.; Szeto, J.; Tamez, M.; Mattei, J. The role of polyphenols in human health and food systems: A mini-review. Front. Nutr. 2018, 5, 87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Wang, Y.H.; Hou, A.J.; Zhu, G.F.; Chen, D.F.; Sun, H.D. Cytotoxic and antifungal isoprenylated xanthones and flavonoids from Cudrania fruticosa. Planta Med. 2005, 71, 273–274. [Google Scholar] [CrossRef]
  26. Zhang, Z.; Yuan, W.; Wang, P.; Grant, G.; Li, S. Flavonoids from Lupinus texensis and their free radical scavenging activity. Nat. Prod. Res. 2011, 25, 1641–1649. [Google Scholar] [CrossRef]
  27. Wei, S.; Wu, W.; Ji, Z. New antifungal pyranoisoflavone from Ficus tikoua bur. Int. J. Mol. Sci. 2012, 13, 7375–7382. [Google Scholar] [CrossRef] [Green Version]
  28. Akter, K.; Barnes, E.C.; Loa-Kum-Cheung, W.L.; Yin, P.; Kichu, M.; Brophy, J.J.; Barrow, R.A.; Imchen, I.; Vemulpad, S.R.; Jamie, J.F. Antimicrobial and antioxidant activity and chemical characterisation of Erythrina stricta Roxb. (Fabaceae). J. Ethnopharmacol. 2016, 185, 171–181. [Google Scholar] [CrossRef]
  29. Lowry, J.L.; Brovkovych, V.; Zhang, Y.; Skidgel, R.A. Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium. J. Biol. Chem. 2013, 288, 4174–4193. [Google Scholar] [CrossRef] [Green Version]
  30. Rapovy, S.M.; Zhao, J.; Bricker, R.L.; Schmidt, S.M.; Setchell, K.D.R.; Qualls, J.E. Differential requirements for l-citrulline and l-arginine during antimycobacterial macrophage activity. J. Immunol. 2015, 195, 3293–3300. [Google Scholar] [CrossRef] [Green Version]
  31. Sarti, P.; Forte, E.; Mastronicola, D.; Giuffrè, A.; Arese, M. Cytochrome c oxidase and nitric oxide in action: Molecular mechanisms and pathophysiological implications. Biochim. Biophys. Acta Bioenerg. 2012, 1817, 610–619. [Google Scholar] [CrossRef] [PubMed]
  32. Grottelli, S.; Amoroso, R.; Macchioni, L.; D’Onofrio, F.; Fettucciari, K.; Bellezza, I.; Maccallini, C. Acetamidine-based iNOS inhibitors as molecular tools to counteract inflammation in BV2 microglial cells. Molecules 2020, 25, 2646. [Google Scholar] [CrossRef]
  33. Muniandy, K.; Gothai, S.; Badran, K.M.H.; Kumar, S.S.; Esa, N.M.; Arulselvan, P. Suppression of proinflammatory cytokines and mediators in LPS-Induced RAW 264.7 macrophages by stem extract of Alternanthera sessilis via the inhibition of the NF-κB pathway. J. Immunol. Res. 2018, 2018, 3430684. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Li, X.; Chen, D.; Li, M.; Gao, X.; Shi, G.; Zhao, H. Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells. Biomed. Pharmacother. 2018, 102, 1045–1051. [Google Scholar] [CrossRef] [PubMed]
  35. Jin, H.G.; Kim, A.R.; Ko, H.J.; Lee, S.K.; Woo, E.R. Three new lignan glycosides with IL-6 inhibitory activity from Akebia quinata. Chem. Pharm. Bull. 2014, 62, 288–293. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Yoo, H.; Ku, S.K.; Baek, Y.D.; Bae, J.S. Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo. Inflamm. Res. 2014, 63, 197–206. [Google Scholar] [CrossRef]
  37. Newton, K.; Dixit, V.M. Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 2012, 4, a006049. [Google Scholar] [CrossRef]
  38. Meng, T.; Yu, J.; Lei, Z.; Wu, J.; Wang, S.; Bo, Q.; Zhang, X.; Ma, Z.; Yu, J. Propofol reduces lipopolysaccharide-induced, NADPH oxidase (NOX 2) mediated TNF- α and IL-6 production in macrophages. Clin. Dev. Immunol. 2013, 2013, 325481. [Google Scholar] [CrossRef] [Green Version]
  39. Tucsek, Z.; Radnai, B.; Racz, B.; Debreceni, B.; Priber, J.K.; Dolowschiak, T.; Palkovics, T.; Gallyas, F.; Sumegi, B.; Veres, B. Suppressing LPS-induced early signal transduction in macrophages by a polyphenol degradation product: A critical role of MKP-1. J. Leukoc. Biol. 2011, 89, 105–111. [Google Scholar] [CrossRef]
  40. Ryan, K.A.; Smith, M.F.; Sanders, M.K.; Ernst, P.B. Reactive oxygen and nitrogen species differentially regulate toll-like receptor 4-mediated activation of NF-κB and interleukin-8 expression. Infect. Immun. 2004, 72, 2123–2130. [Google Scholar] [CrossRef] [Green Version]
  41. Grauzdytė, D.; Pukalskas, A.; Viranaicken, W.; Kalamouni, C.E.; Venskutonis, P.R. Protective effects of Phyllanthus phillyreifolius extracts against hydrogen peroxide induced oxidative stress in HEK293 cells. PLoS ONE 2018, 13, e0207672. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Bedard, K.; Krause, K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007, 87, 245–313. [Google Scholar] [CrossRef] [PubMed]
  43. Ci, X.; Zhou, J.; Lv, H.; Yu, Q.; Peng, L.; Hua, S. Betulin exhibits anti-inflammatory activity in LPS-stimulated macrophages and endotoxin-shocked mice through an AMPK/AKT/Nrf2-dependent mechanism. Cell Death Dis. 2017, 8, e2798. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Guangwei, Z.; An, H.; Dong, F.; Wei, W.; Yang, H.; Cheng, L. Plantamajoside protects H9c2 cells against hypoxia/reoxygenation-induced injury through regulating the akt/Nrf2/HO-1 and NF-κB signaling pathways. J. Recept. Signal Transduct. Res. 2020, 22, 1–8. [Google Scholar]
  45. Shaul, Y.D.; Seger, R. The MEK/ERK cascade: From signaling specificity to diverse functions. Biochim. Biophys. Acta Mol. Cell Res. 2007, 1773, 1213–1226. [Google Scholar] [CrossRef] [Green Version]
  46. Li, C.; Chen, T.; Zhou, H.; Zhang, C.; Feng, Y.; Tang, F.; Hoi, M.P.M.; He, C.; Zheng, Y.; Lee, S.M.Y. Schisantherin a attenuates neuroinflammation in activated microglia: Role of Nrf2 activation through ERK phosphorylation. Cell. Physiol. Biochem. 2018, 47, 1769–1784. [Google Scholar] [CrossRef]
  47. Hua, K.F.; Chou, J.C.; Lam, Y.; Tasi, Y.L.; Chen, A.; Ka, S.M.; Fang, Z.; Liu, M.L.; Yang, F.L.; Yang, Y.L.; et al. Polyenylpyrrole Derivatives Inhibit NLRP3 Inflammasome Activation and Inflammatory Mediator Expression by Reducing Reactive Oxygen Species Production and Mitogen-Activated Protein Kinase Activation. PLoS ONE 2013, 8, e76754. [Google Scholar] [CrossRef] [Green Version]
  48. Scherle, P.A.; Jones, E.A.; Favata, M.F.; Daulerio, A.J.; Covington, M.B.; Nurnberg, S.A.; Magolda, R.L.; Trzaskos, J.M. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J. Immunol. 1998, 161, 5681–5686. [Google Scholar]
  49. Low, H.B.; Zhang, Y. Regulatory roles of MAPK phosphatases in cancer. Immune Netw. 2016, 16, 85–98. [Google Scholar] [CrossRef] [Green Version]
  50. Bognar, E.; Sarszegi, Z.; Szabo, A.; Debreceni, B.; Kalman, N.; Tucsek, Z.; Sumegi, B.; Gallyas, F. Antioxidant and anti-Inflammatory effects in RAW264.7 macrophages of malvidin, a major red wine polyphenol. PLoS ONE 2013, 8, e65355. [Google Scholar] [CrossRef]
Antioxidants 10 00070 g001 550
Figure 1. Antioxidant activities of methanol extracts obtained from Abeliophyllum distichum organs. Antioxidant activities were analyzed using the reducing power assay (A), the ORAC assay (B), DPPH free radical scavenging activity (C), ABTS cation radical scavenging activity (D), and hydroxyl radical scavenging activity (E). The ORAC value of each sample is expressed as micromol of Trolox (TE) equivalents. Each value represents the mean ± SE of triplicate measurements. Different superscripted letters are used to indicate the significant differences (p < 0.05). Leaf extract, AL; fruit extract, AF; branch extract, AB; ascorbic acid, ASA.
Figure 1. Antioxidant activities of methanol extracts obtained from Abeliophyllum distichum organs. Antioxidant activities were analyzed using the reducing power assay (A), the ORAC assay (B), DPPH free radical scavenging activity (C), ABTS cation radical scavenging activity (D), and hydroxyl radical scavenging activity (E). The ORAC value of each sample is expressed as micromol of Trolox (TE) equivalents. Each value represents the mean ± SE of triplicate measurements. Different superscripted letters are used to indicate the significant differences (p < 0.05). Leaf extract, AL; fruit extract, AF; branch extract, AB; ascorbic acid, ASA.
Antioxidants 10 00070 g001
Antioxidants 10 00070 g002 550
Figure 2. Anti-inflammatory effect of Abeliophyllum distichum organ extracts in LPS-treated RAW264.7 macrophages. (A) Effect of A. distichum organ extracts on LPS-induced NO production. Dose-dependent effect of A. distichum leaf extract on LPS-induced NO production (B) and cytotoxicity (C) in RAW264.7 macrophages. Mean ± SE with different letters indicate the significant differences (p < 0.05). Leaf extract, AL; fruit extract, AF; branch extract, AB.
Figure 2. Anti-inflammatory effect of Abeliophyllum distichum organ extracts in LPS-treated RAW264.7 macrophages. (A) Effect of A. distichum organ extracts on LPS-induced NO production. Dose-dependent effect of A. distichum leaf extract on LPS-induced NO production (B) and cytotoxicity (C) in RAW264.7 macrophages. Mean ± SE with different letters indicate the significant differences (p < 0.05). Leaf extract, AL; fruit extract, AF; branch extract, AB.
Antioxidants 10 00070 g002
Antioxidants 10 00070 g003 550
Figure 3. Effect of Abeliophyllum distichum leaf extract on the expression level (A), and protein level (B) of iNOS in LPS-treated RAW264.7 macrophages. The transcription and translation levels of iNOS were investigated using qRT-PCR (A) and western blot (B). All data are reported as mean ± SE. Different superscripted letters are used to indicate the significant differences (p < 0.05).
Figure 3. Effect of Abeliophyllum distichum leaf extract on the expression level (A), and protein level (B) of iNOS in LPS-treated RAW264.7 macrophages. The transcription and translation levels of iNOS were investigated using qRT-PCR (A) and western blot (B). All data are reported as mean ± SE. Different superscripted letters are used to indicate the significant differences (p < 0.05).
Antioxidants 10 00070 g003
Antioxidants 10 00070 g004 550
Figure 4. Effect of Abeliophyllum distichum leaf extract on COX-2 and IL-6 expression in LPS-treated RAW264.7 macrophages. Gene transcript levels were normalized to β-actin and were expressed relative to the value of LPS alone. Different superscripted letters indicate the significant differences (p < 0.05).
Figure 4. Effect of Abeliophyllum distichum leaf extract on COX-2 and IL-6 expression in LPS-treated RAW264.7 macrophages. Gene transcript levels were normalized to β-actin and were expressed relative to the value of LPS alone. Different superscripted letters indicate the significant differences (p < 0.05).
Antioxidants 10 00070 g004
Antioxidants 10 00070 g005 550
Figure 5. Effects of Abeliophyllum distichum leaf extract on LPS-induced ROS production in RAW264.7 macrophages. The inhibitory effect of A. distichum leaf (AL) or branch (AB) extract on LPS-induced ROS production was determined using the DCFH-DA (A). LPS-treated RAW264.7 cells in the presence of AL were used to analyze the expression level of genes involved in ROS production (B), cellular oxygen metabolism (C), and Nrf2-targeted antioxidant and detoxification (D). The transcript levels of each gene was normalized to β-actin and expressed relative to the value of LPS alone. All data were reported as the mean ± SE. Different superscripted letters indicate the significant differences (p < 0.05).
Figure 5. Effects of Abeliophyllum distichum leaf extract on LPS-induced ROS production in RAW264.7 macrophages. The inhibitory effect of A. distichum leaf (AL) or branch (AB) extract on LPS-induced ROS production was determined using the DCFH-DA (A). LPS-treated RAW264.7 cells in the presence of AL were used to analyze the expression level of genes involved in ROS production (B), cellular oxygen metabolism (C), and Nrf2-targeted antioxidant and detoxification (D). The transcript levels of each gene was normalized to β-actin and expressed relative to the value of LPS alone. All data were reported as the mean ± SE. Different superscripted letters indicate the significant differences (p < 0.05).
Antioxidants 10 00070 g005
Antioxidants 10 00070 g006 550
Figure 6. Inhibition of ERK1/2 activation by A. distichum leaf extract in LPS-treated RAW264.7 macrophages. The activation of MEK1/2 and ERK 1/2 was analyzed by western blot.
Figure 6. Inhibition of ERK1/2 activation by A. distichum leaf extract in LPS-treated RAW264.7 macrophages. The activation of MEK1/2 and ERK 1/2 was analyzed by western blot.
Antioxidants 10 00070 g006
Table
Table 1. Phytochemical constituents identified in Abeliophyllum distichum leaf (AL), fruit (AF), and branch (AB) extracts.
Table 1. Phytochemical constituents identified in Abeliophyllum distichum leaf (AL), fruit (AF), and branch (AB) extracts.
Peak No.Rt (min)Neutral Mass (Da)Observed m/zMass Error (mDa)FormulaProposed MoleculeFragment IonsOrgan
10.52192.0634191.0555−0.6C7H12O6D-(−)-Quinic acid173.04, 149.04, 127.04, 109.03, 93.03, 85.03AF, AB, AL
25.43446.2152445.2074−0.5C21H34O10Dendromoniliside D401.14, 269.10, 229.07, 185.04, 141.02, 103.04AL
37.02772.2426771.2342−1.1C32H36O22α-Glucosyl hesperidin661.18, 607.19, 591.19, 229.07, 179.03, 161.02AB
47.09640.2003639.1922−0.9C29H36O16Plantamajoside475.14, 185.04, 179.03, 161.02AL
57.37478.1475477.1399−0.4C23H26O11Calceolarioside B221.04, 161.02AL
67.50786.2582785.2512−0.3C35H46O20Echinacoside624.22, 429.15, 387.15, 305.09, 179.03, 161.02, 135.04AF
78.01610.1534609.1459−0.2C27H30O16Rutin301.03, 300.03, 299.02AF, AB, AL
88.14488.3138487.3055−1.0C24H40O10Senegenic acid367.27, 309.22, 290.22, 225.16AF, AL
98.48462.1526461.1451−0.2C23H26O106′-coumaroyl-1′-O-[2-(3,4-dihydroxyphenyl)ethyl]-β-d-glucopyranoside265.07, 205.05, 163.04, 145.03AF, AL
108.56464.1682463.1599−1.1C21H20O12Isomucronulatol 7-O-Glucoside341.06, 327.04, 222.09, 141.02, 137.02AL
118.64756.2477755.2397−0.7C32H38O20Forsythoside B725.23, 593.21, 325.09, 275.08, 179.03, 161.03, 135.04AF, AB
128.96624.2054623.1979−0.2C29H36O15Isoacteoside461.16, 179.03, 161.02AF, AB, AL
139.25520.1945519.1869−0.3C23H22O13Brusatol465.18, 447.09, 357.13, 342.11, 209.08, 103.04AB
149.94374.1366373.1292−0.0C20H22O7(−)-Nortrachelogenin343.12, 313.11, 207.07, 181.05, 145.03AB, AL
1512.42358.1416357.1343−0.1C19H18O7Miroestrol342.11, 299.09, 195.07, 151.04, 122.04AB
1612.72338.1154337.1081−0.0C20H18O5Wighteone295.06, 267.07, 190.06, 175.04, 151.04AB
1713.09534.2465533.2393−0.1C24H22O14Bulleyanin383.11, 343.16, 341.14, 163.04, 145.03, 121.03AL
1813.98436.2097435.2027−0.2C21H24O10Polhovolide229.07, 227.11, 185.04, 163.00, 141.02AF, AL
1920.65488.3502487.3425−0.4C30H48O5Asiatic acid455.32, 409.31AF, AB, AL
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yoo, T.-K.; Jeong, W.T.; Kim, J.G.; Ji, H.S.; Ahn, M.-A.; Chung, J.-W.; Lim, H.B.; Hyun, T.K. UPLC-ESI-Q-TOF-MS-Based Metabolite Profiling, Antioxidant and Anti-Inflammatory Properties of Different Organ Extracts of Abeliophyllum distichum. Antioxidants 2021, 10, 70. https://doi.org/10.3390/antiox10010070

AMA Style

Yoo T-K, Jeong WT, Kim JG, Ji HS, Ahn M-A, Chung J-W, Lim HB, Hyun TK. UPLC-ESI-Q-TOF-MS-Based Metabolite Profiling, Antioxidant and Anti-Inflammatory Properties of Different Organ Extracts of Abeliophyllum distichum. Antioxidants. 2021; 10(1):70. https://doi.org/10.3390/antiox10010070

Chicago/Turabian Style

Yoo, Tong-Kewn, Won Tae Jeong, Jun Gu Kim, Hyo Seong Ji, Min-A Ahn, Jong-Wook Chung, Heung Bin Lim, and Tae Kyung Hyun. 2021. "UPLC-ESI-Q-TOF-MS-Based Metabolite Profiling, Antioxidant and Anti-Inflammatory Properties of Different Organ Extracts of Abeliophyllum distichum" Antioxidants 10, no. 1: 70. https://doi.org/10.3390/antiox10010070

APA Style

Yoo, T. -K., Jeong, W. T., Kim, J. G., Ji, H. S., Ahn, M. -A., Chung, J. -W., Lim, H. B., & Hyun, T. K. (2021). UPLC-ESI-Q-TOF-MS-Based Metabolite Profiling, Antioxidant and Anti-Inflammatory Properties of Different Organ Extracts of Abeliophyllum distichum. Antioxidants, 10(1), 70. https://doi.org/10.3390/antiox10010070

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop